REFRESH OPTIVE Mega-3 (Allergan, Inc.)


Welcome to the PulseAid listing for the REFRESH OPTIVE Mega-3 drug offered from Allergan, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Allergan, Inc.
NON-PROPRIETARY NAME: Carboxymethylcellulose sodium, Glycerin and Polysorbate 80
SUBSTANCE NAME: CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2017-05-30
END MARKETING DATE: 0000-00-00


REFRESH OPTIVE Mega-3 HUMAN OTC DRUG Details:

Item DescriptionREFRESH OPTIVE Mega-3 from Allergan, Inc.
LABELER NAME: Allergan, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5; 10; 5(mg/mL; mg/mL; mg/mL)
START MARKETING DATE: 2017-05-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0023-5773_bad13e61-f80c-47f1-a061-f779694e6d56
PRODUCT NDC: 0023-5773
APPLICATION NUMBER: part349

Other CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN; POLYSORBATE 80 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.REFRESH OPTIVE Advanced